Targeted therapies for treatment of recurrent ovarian cancer Academic Article Article uri icon

Overview

MeSH Major

  • Genomics
  • Neoplasms
  • Precision Medicine

abstract

  • Ovarian cancer remains the leading cause of death among women with gynecologic malignancies in the United States. Most women with epithelial ovarian cancer present with advanced disease. Despite good response rates to initial surgery and chemotherapy, the majority of patients experience relapse and ultimately die of their disease. A better understanding of the molecular differences underlying the histologic subtypes of epithelial ovarian cancer has led to recent advances in targeted therapeutic strategies. Here we review the most promising targeted therapeutics currently being used for the treatment of recurrent ovarian cancer.

publication date

  • January 2014

Research

keywords

  • Academic Article

Identity

PubMed ID

  • 24927263

Additional Document Info

start page

  • 158

end page

  • 62

volume

  • 12

number

  • 3